• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy
  • Reports
    • Diabetes Technology Innovations Special Report
    • Continuous Glucose Monitoring (CGM) Market Report

This new PTFE seal could make insulin pumps and other medical devices better

April 26, 2018 By Chris Newmarker

In dynamic applications requiring sealing at low-to-moderate speeds and pressures, design engineers are replacing underperforming elastomeric O-rings with spring-energized PTFE “C-ring” seals.

David Wang, Bal Seal Engineering

Bal Seal C-ring PTFE sealWhen O-rings and other traditional sealing methods fail, diagnostic and drug-delivery equipment engineers are embracing a new and more cost-effective way to improve the performance of their existing hardware designs: The spring-energized PTFE “C-ring” seal.

The challenge: replacing a failed O-ring

The C-ring seal was first developed for a diagnostic tool employing a piston operating in a water bath of approximately 100°F, reciprocating at a rate of 5 feet per minute. The operating conditions were mild, but the tolerances were large. The original design called for an elastomeric O-ring to seal the piston, but the O-ring was unable to maintain a consistent seal and the equipment leaked.

With prototypes already built, engineers began looking for an alternative. U-cups or standard lip seals, which would typically be used in a piston application, were not a viable option because of large radial tolerances. Also, installing these over a full-step groove wasn’t practical. The installation would require too much stretching, resulting in seal deformation and premature failure.

Get the full story on our sister site Medical Design & Outsourcing.

Filed Under: Featured, Technology Tagged With: balsealengineering

IN CASE YOU MISSED IT

  • Dexcom CFO to expand into COO role
  • Beta Bionics insulin patch pump scores FDA clearance
  • Medtronic moves to divest final stake in MiniMed
  • Dexcom adds former Stryker CFO to board
  • MiniMed wins CE mark for next-gen insulin pump, ups revenue guidance

About Chris Newmarker

Chris Newmarker is the executive editor of WTWH Media life science's news websites and publications including MassDevice, Medical Design & Outsourcing and more. A professional journalist of 18 years, he is a veteran of UBM (now Informa) and The Associated Press whose career has taken him from Ohio to Virginia, New Jersey and, most recently, Minnesota. He’s covered a wide variety of subjects, but his focus over the past decade has been business and technology. He holds bachelor’s degrees in journalism and political science from Ohio State University. Connect with him on LinkedIn or email at [email protected].

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.
MDO

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
About
Contact us
Listen to our Weekly Podcasts
Advertise

Copyright © 2026 · Arrowfly LLC. All Rights Reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy | Terms & Conditions | RSS